Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[RichDude]

But, you are still holding, LOL. Seems you may actually understand how BioTechs companies really work. Drugs take *many* years to make it to market, depending on the uniqueness of the disease or condition they treat.

Now, if I were holding out for just one drug, then, I would agree, it may not go up. But, that is not the case on this one. 3 drugs, one in development, one in phase 3, and, one FDA approved for the U.S. SO, this isn't a one hit wonder.

What we have here is a GENE Biotech, which, isn't even your typical BIO tech to start with. GENE research has *many* applications from STEM CELL to CANCER. I included a direct link to a 78 page introduction / presentation on the company, in a previous post. And, they are being invited to present a conferences across the country, regarding their current phase 3 trial.